Your Professional Tirzepatide Supplier
Hubei Bosetech Chemical Co., Ltd. specializes in the production and export of chemical raw materials, peptides, and cosmetic ingredients. The company has established strategic partnerships with domestic manufacturers and laboratories affiliated with renowned universities to meet diverse customer demands ranging from grams to tonnage quantities.
Quality Control
We uphold high standards by implementing rigorous management practices for production processes and quality control. All products undergo comprehensive quality testing before being delivered to customers.
Professional Team
Our company boasts a team of highly experienced R&D management personnel who possess expertise in new drug research and development technology and management systems. This team covers the entire chain of new drug product development, from R&D to production technology, under the leadership of internationally recognized experts.
Sales Market
We conduct business with over 60 countries worldwide, with primary markets including Central and South America, Southeast Asia, Central Asia, Africa, the Middle East, Eastern Europe, and Russia. Our market presence continues to expand globally.
Parameter
|
CAS Number |
2023788-19-2 |
|
Appearance |
White powder |
|
Purity(HPLC) |
≥95.0% |
|
Amino acid composition analysis |
≤±10% |
|
Acetic acid content |
5.0% ~ 12.0% |
|
Moisture content |
≤8.0% |
|
Peptide content |
≥75.0% |
|
Storage method |
Freeze-drying at -20℃ and storage away from light |
|
Note |
For research purposes only, not for human use |
Types of Tirzepatide
The tirzepatides produced by our company mainly include the following types:
Tirzepatide-5mg
Tirzepatide-5mg has a good effect in controlling blood sugar. It can effectively reduce the level of glycosylated hemoglobin (HbA1c), usually reducing HbA1c by about 1.5-2%.
Tirzepatide-10mg
Tirzepatide-10mg was more effective in lowering blood sugar. Compared to the 5mg dose, it can reduce the glycosylated hemoglobin (HbA1c) more, possibly by about 2-2.5%.
Tirzepatide-15mg
Tirzepatide15mg dose has a more significant effect in controlling blood sugar. It may reduce glycosylated hemoglobin (HbA1c) more than the 10mg and 5mg doses, reducing HbA1c by about 2.5-3%.
Advantages of Tirzepatide
Significant Weight Loss
Clinical trials have demonstrated that tirzepatide leads to significant weight loss in individuals with obesity and/or type 2 diabetes. Compared to other medications, tirzepatide has shown superior efficacy in promoting weight reduction.
Dual Receptor Agonism
Tirzepatide acts as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual mechanism of action enhances its effectiveness in regulating appetite, glucose metabolism, and energy balance.
Improved Glycemic Control
In addition to weight loss, tirzepatide helps improve glycemic control by lowering blood sugar levels. Its dual receptor agonism targets multiple pathways involved in glucose regulation, leading to better management of diabetes.
Cardiovascular Benefits
Tirzepatide has shown cardiovascular benefits beyond weight loss and glycemic control. Studies suggest that it may lower blood pressure and reduce the risk of cardiovascular events, such as heart attacks and strokes, in individuals with type 2 diabetes and established cardiovascular disease.
Once-Weekly Dosage
Tirzepatide is administered once weekly as a subcutaneous injection, offering convenience and improved adherence compared to medications that require daily dosing. This simplified dosing regimen may enhance patient compliance and treatment outcomes.
Reduction in Cardiovascular Risk Factors
In addition to cardiovascular benefits, tirzepatide has been shown to reduce other risk factors associated with heart disease, such as blood pressure and lipid levels. This comprehensive approach addresses multiple aspects of cardiometabolic health.
Improved Insulin Sensitivity
Tirzepatide improves insulin sensitivity, allowing cells to better respond to insulin and utilize glucose for energy. By enhancing insulin action, tirzepatide helps normalize blood sugar levels and reduces the risk of insulin resistance-related complications.
Potential for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
Preliminary studies suggest that tirzepatide may have beneficial effects on non-alcoholic fatty liver disease (NAFLD), a common condition associated with obesity and insulin resistance. Tirzepatide's metabolic effects could help mitigate liver fat accumulation and inflammation.
Quality of Life Improvement
Lastly, tirzepatide can significantly improve the quality of life for individuals with obesity and type 2 diabetes by reducing symptoms, such as fatigue, thirst, and frequent urination, associated with uncontrolled hyperglycemia. Weight loss and better glycemic control contribute to overall well-being and functional status.
Applications of Tirzepatide
Managing Type 2 Diabetes
Tirzepatide is FDA-approved for treating type 2 diabetes . Clinical trials have shown that tirzepatide lowers HbA1c levels more effectively than semaglutide, making it a top choice for patients seeking better glycemic control.
Weight Loss Treatment
Tirzepatide is approved for weight loss in adults with obesity or overweight conditions. In clinical trials, users lost up to 20% of their body weight , surpassing the results achieved with semaglutide.
Tirzepatide Dosing Information
Usual Zepbound Dose for Weight Loss and OSA (Adult)
Initial dose: 2.5 mg under the skin (subcutaneously) once a week.
After 4 weeks: The dosage should be increased to 5 mg subcutaneously once a week.
Further dose increases: After at least 4 weeks on the current dose the dosage may be increased in 2.5 mg increments.
Recommended maintenance dose for weight loss: 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly.
Recommended maintenance dose for OSA: 10 mg or 15 mg injected subcutaneously once weekly.
Maximum dose: 15 mg subcutaneously once a week.
Usual Dose for Diabetes Type 2 (Adult)
Initial dose: 2.5 mg under the skin (subcutaneously) once a week.
After 4 weeks: The dosage should be increased to 5 mg subcutaneously once a week.
If additional glycemic control is needed: The dosage should be increased in 2.5 mg increments after at least 4 weeks on the current dose.
Maximum dose: 15 mg subcutaneously once a week.
Comments: The 2.5 mg dosage is for starting treatment and is not intended for glycemic control. The day of weekly administration can be changed, if necessary, as long as the time between the 2 doses is at least 3 days (72 hours).
Precautions When Taking Tezetribote
Follow a Balanced Diet
Focus on nutrient-dense foods and avoid processed foods and sugary beverages.
Stay Active
Incorporate at least 150 minutes of moderate-intensity exercise per week, such as walking, cycling, or swimming.
Monitor Progress
Track your blood sugar levels and weight regularly to assess the medication’s effectiveness.
Communicate with Your Doctor
Report any side effects or concerns promptly to ensure your treatment plan remains safe and effective.
Packaging and Transport
|
Packaging |
1kg/Bag 10kg/Box 25kg/Drum |
|
Transport |
We can accept sea freight, air freight, and express delivery, with a guarantee time of 1-2 weeks and a customs clearance rate of over 99%. Even if the goods are detained, you can resend the freight and I will resend the goods. |
Qualification And Certificate
FAQ
We're professional tirzepatide manufacturers and suppliers in China, specialized in providing high quality products and service. We warmly welcome you to buy cost-efficient tirzepatide for sale here from our factory. For price consultation, contact us.
CAS 2023788 19 2, Tirzepatide Powder, Tirzepatide-15mg